RAN-DONEPEZIL
« Back to list view

Product Information

  • DIN:
    02381508
  • Active Ingredients :
    donepezil hydrochloride
  • Innovator Name:
    Aricept®
  • Category:
    Cholinesterase Inhibitor
  • Dosage form:
    Tablet
  • Strength:
    5mg
  • Package size:
    100 Bottle 500 Bottle
  • UPC Code:
    876515005270 876515005287
  • Non-medicinal ingredients :
    lactose monohydrate, maize starch, microcrystalline cellulose, hypromellose and magnesium stearate. The film coating contains talc, polyethylene glycol, hypromellose and titanium dioxide. Additionally, the 10-mg tablet contains iron oxide yellow as a coloring agent
RAN-DONEPEZIL

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02381516
  • Active Ingredients :
    donepezil hydrochloride
  • Innovator Name:
    Aricept®
  • Category:
    Cholinesterase Inhibitor
  • Dosage form:
    Tablet
  • Strength:
    10mg
  • Package size:
    100 Bottle 500 Bottle
  • UPC Code:
    876515005294 876515005300
  • Non-medicinal ingredients :
    lactose monohydrate, maize starch, microcrystalline cellulose, hypromellose and magnesium stearate. The film coating contains talc, polyethylene glycol, hypromellose and titanium dioxide. Additionally, the 10-mg tablet contains iron oxide yellow as a coloring agent
RAN-DONEPEZIL

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here